Skip to main content
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie 1/2017

09.02.2017 | Ablationstherapie | Schwerpunkt

Komplikationen elektrophysiologischer Eingriffe im Alter

verfasst von: Prof. Dietrich Pfeiffer, Martin Neef, Daniel Jurisch, Andreas Hagendorff

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Vorliegende Register geben wenig valide Informationen zu altersbedingten Komplikationen. Dafür gibt es vielfältige Gründe, wie die nicht für alle Altersgruppen ausreichende Zahl erfolgter Eingriffe (z. B. Kontraktilitätsmanagement), die Abhängigkeit mancher Komplikationen von der Erfahrung der Untersucher (z. B. Ablationsbehandlung) oder die veränderten Indikationsstellungen (z. B. Resynchronisation). Schließlich werden vielerorts schwerstkranke und sehr alte Patienten mit absehbar begrenzter Prognose in der klinischen Praxis manchen elektrophysiologischen Therapien nicht ausgesetzt. Aus all diesen Gründen sind registerbasierte Zahlen nur begrenzt interpretierbar. Metaanalysen randomisierter Studien geben präzisere Aussagen zu den eingeschlossenen Patientengruppen, spiegeln jedoch den klinischen Alltag nicht unbedingt wider, weil mehr oder weniger große Patientengruppen alter Menschen aus der täglichen Routine für Studien ausgeschlossen sind. Damit muss die Beurteilung des individuellen Risikos eines alten Patienten während und nach einem elektrophysiologischen Eingriff im Einzelfall beurteilt werden. In jedem Fall dürfte das kalendarische Alter hinsichtlich möglicher Komplikationen nicht so relevant sein, dass es für elektrophysiologische Eingriffe strikte Altersgrenzen geben muss. Es gibt trotz aller vorliegenden Daten bislang keine Alternative zur individuellen Risikobeurteilung des aufgeklärten alten Patienten durch einen informierten und erfahrenen Kardiologen.
Literatur
2.
Zurück zum Zitat Özcan KS, Osmonov D, Altay S, Dönmez C, Yildirim E, Türkkan C, Güngör B, Ekmekci A, Alper AT, Gürkan K, Erdlindler I (2013) Pacemaker implantation complication rates in elderly and young patients. Clin Interv Aging 8:1051–1054CrossRef Özcan KS, Osmonov D, Altay S, Dönmez C, Yildirim E, Türkkan C, Güngör B, Ekmekci A, Alper AT, Gürkan K, Erdlindler I (2013) Pacemaker implantation complication rates in elderly and young patients. Clin Interv Aging 8:1051–1054CrossRef
3.
Zurück zum Zitat Armaganijan LV, Toff WD, Nielsen JC, Andersen HR, Connolly SJ, Ellenbogen KA, Healy JS (2012) Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol 35:121–124CrossRef Armaganijan LV, Toff WD, Nielsen JC, Andersen HR, Connolly SJ, Ellenbogen KA, Healy JS (2012) Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol 35:121–124CrossRef
4.
Zurück zum Zitat Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA et al (1998) Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker selection in the elderly investigators (PASE). N Engl J Med 338:1097–1104CrossRef Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA et al (1998) Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker selection in the elderly investigators (PASE). N Engl J Med 338:1097–1104CrossRef
9.
Zurück zum Zitat Yung D, Birnie D, Dorian P, Healey JS, Simpson CS, Crystal E, Krahn AD, Khaykin Y, Cameron D, Chen Z, Lee DS (2013) Survival after implantable cardioverter-defibrillator implantation in the elderly. Clinical perspective. Circulation 127:2383–2392CrossRef Yung D, Birnie D, Dorian P, Healey JS, Simpson CS, Crystal E, Krahn AD, Khaykin Y, Cameron D, Chen Z, Lee DS (2013) Survival after implantable cardioverter-defibrillator implantation in the elderly. Clinical perspective. Circulation 127:2383–2392CrossRef
10.
Zurück zum Zitat Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD et al (2009) Review of the ICD registry’s third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 6:1397–1401CrossRef Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD et al (2009) Review of the ICD registry’s third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 6:1397–1401CrossRef
11.
Zurück zum Zitat Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD et al (2006) The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 47:2493–2497CrossRef Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD et al (2006) The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 47:2493–2497CrossRef
12.
Zurück zum Zitat Duray G, Richter S, Manegold J, Israel CW, Grönefeld G, Hohnloser SH (2005) Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol 14:169–173CrossRef Duray G, Richter S, Manegold J, Israel CW, Grönefeld G, Hohnloser SH (2005) Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol 14:169–173CrossRef
13.
Zurück zum Zitat van Rees JB, Borleffs CJ, Thijssen J, de Bie MK, van Erven L, Cannegieter SC et al (2012) Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace 14:66–73CrossRef van Rees JB, Borleffs CJ, Thijssen J, de Bie MK, van Erven L, Cannegieter SC et al (2012) Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace 14:66–73CrossRef
14.
Zurück zum Zitat Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH (2008) Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002–2005. Circ Arrhythm Electrophysiol 1:240–249CrossRef Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH (2008) Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002–2005. Circ Arrhythm Electrophysiol 1:240–249CrossRef
15.
Zurück zum Zitat Noseworthy PA, Lashevsky I, Dorian P, Greene M, Cvitkovic S, Newman D (2004) Feasibility of implantable cardioverter defibrillator use in elderly patients: a case series of octogenarians. Pacing Clin Electrophysiol 27:373–378CrossRef Noseworthy PA, Lashevsky I, Dorian P, Greene M, Cvitkovic S, Newman D (2004) Feasibility of implantable cardioverter defibrillator use in elderly patients: a case series of octogenarians. Pacing Clin Electrophysiol 27:373–378CrossRef
16.
Zurück zum Zitat Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA (2011) National Cardiovascular Data’sICD Registry. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes 4:549–556CrossRef Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA (2011) National Cardiovascular Data’sICD Registry. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes 4:549–556CrossRef
17.
Zurück zum Zitat Santangeli P, Di Biase L, Dello RA, Casella M, Bartoletti S, Santarelli P et al (2010) Meta-analysis: age and effectiveness of prophylactic implantable cardioverter defibrillators. Ann Intern Med 153:592–599CrossRef Santangeli P, Di Biase L, Dello RA, Casella M, Bartoletti S, Santarelli P et al (2010) Meta-analysis: age and effectiveness of prophylactic implantable cardioverter defibrillators. Ann Intern Med 153:592–599CrossRef
18.
Zurück zum Zitat Barra S, Providencia R, Paiva L, Heck P, Agarwal S (2015) Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace 17:174–186CrossRef Barra S, Providencia R, Paiva L, Heck P, Agarwal S (2015) Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace 17:174–186CrossRef
19.
Zurück zum Zitat Bailey SM, Wilkoff BL, from the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (2006) Complications of pacemakers and defibrillators in the elderly. Am J Geriatr Cardiol 15:102–107CrossRef Bailey SM, Wilkoff BL, from the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (2006) Complications of pacemakers and defibrillators in the elderly. Am J Geriatr Cardiol 15:102–107CrossRef
20.
Zurück zum Zitat Hasenfuß G, Anker S, Bauersachs S, Böhm M, Hoppe UC, Pieske B, von Scheidt W, Wachter R (2013) Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen Herzinsuffizienz. Kardiologe 7:105–114CrossRef Hasenfuß G, Anker S, Bauersachs S, Böhm M, Hoppe UC, Pieske B, von Scheidt W, Wachter R (2013) Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen Herzinsuffizienz. Kardiologe 7:105–114CrossRef
21.
Zurück zum Zitat Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey JY, Prins MH, Levy S, Crijns HJ, European Heart Survey I (2005) Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 26:2422–2434CrossRef Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey JY, Prins MH, Levy S, Crijns HJ, European Heart Survey I (2005) Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 26:2422–2434CrossRef
22.
Zurück zum Zitat Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Abraham WT, Lincoln NE, Orangeburg NY (2011) A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 161:329–337CrossRef Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Abraham WT, Lincoln NE, Orangeburg NY (2011) A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 161:329–337CrossRef
23.
Zurück zum Zitat Giallauria F, Vigorito C, Piepoli MF, Stewart Coats AJ (2014) Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient’s data meta-analysis of randomized controlled trials. Int J Cardiol 175(2):352–357CrossRef Giallauria F, Vigorito C, Piepoli MF, Stewart Coats AJ (2014) Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient’s data meta-analysis of randomized controlled trials. Int J Cardiol 175(2):352–357CrossRef
24.
Zurück zum Zitat Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32–38CrossRef Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32–38CrossRef
25.
Zurück zum Zitat Piccini JP, Fraulo ES, Ansell JE, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Kong MH, Lopes RD, Mills RM, Peterson ED (2011) Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J 162:606–612.e1CrossRef Piccini JP, Fraulo ES, Ansell JE, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Kong MH, Lopes RD, Mills RM, Peterson ED (2011) Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J 162:606–612.e1CrossRef
26.
Zurück zum Zitat Steinberg BA, Holmes DN, Ezekowitz MD, Fonarow GC, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Chang P, Peterson ED, Piccini JP (2013) Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J 65:622–629CrossRef Steinberg BA, Holmes DN, Ezekowitz MD, Fonarow GC, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Chang P, Peterson ED, Piccini JP (2013) Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J 65:622–629CrossRef
27.
Zurück zum Zitat Holmqvist F, Simon DJ, Steinberg BA, Hong SJ, Kowey PR, Reiffel JA, Naccarelli GV, Chang P, Gersh BJ, Peterson ED, Piccini JP, on behalf of the ORBIT-AF Investigators (2015) Catheter ablation of atrial fibrillation in U.S. community practice – results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). J Am Heart Assoc 4(5):e001901CrossRef Holmqvist F, Simon DJ, Steinberg BA, Hong SJ, Kowey PR, Reiffel JA, Naccarelli GV, Chang P, Gersh BJ, Peterson ED, Piccini JP, on behalf of the ORBIT-AF Investigators (2015) Catheter ablation of atrial fibrillation in U.S. community practice – results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). J Am Heart Assoc 4(5):e001901CrossRef
28.
Zurück zum Zitat Hoyt H, Nazarian S, Alhumaid F, Dalal D, Chilukuri K, Spragg D, Henrikson CA, Sinha S, Cheng A, Edwards D, Needleman M, Marine JE, Berger R, Calkins H (2011) Demographic profile of patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 22:994–998CrossRef Hoyt H, Nazarian S, Alhumaid F, Dalal D, Chilukuri K, Spragg D, Henrikson CA, Sinha S, Cheng A, Edwards D, Needleman M, Marine JE, Berger R, Calkins H (2011) Demographic profile of patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 22:994–998CrossRef
29.
Zurück zum Zitat Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA (2012) Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 59:143–149CrossRef Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA (2012) Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 59:143–149CrossRef
30.
Zurück zum Zitat Piccini JP, Sinner MF, Greiner MA, Hammill BG, Fontes JD, Daubert JP, Ellinor PT, Hernandez AF, Walkey AJ, Heckbert SR, Benjamin EJ, Curtis LH (2012) Outcomes of medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation 126(18):2200–2207CrossRef Piccini JP, Sinner MF, Greiner MA, Hammill BG, Fontes JD, Daubert JP, Ellinor PT, Hernandez AF, Walkey AJ, Heckbert SR, Benjamin EJ, Curtis LH (2012) Outcomes of medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation 126(18):2200–2207CrossRef
31.
Zurück zum Zitat Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM (2009) Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2:626–633CrossRef Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM (2009) Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2:626–633CrossRef
33.
Zurück zum Zitat Le Heuzey JY, Breithardt G, Camm J, Crijns H, Dorian P, Kowey PR, Merioua I, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W (2010) The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol 105:687–693CrossRef Le Heuzey JY, Breithardt G, Camm J, Crijns H, Dorian P, Kowey PR, Merioua I, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W (2010) The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol 105:687–693CrossRef
Metadaten
Titel
Komplikationen elektrophysiologischer Eingriffe im Alter
verfasst von
Prof. Dietrich Pfeiffer
Martin Neef
Daniel Jurisch
Andreas Hagendorff
Publikationsdatum
09.02.2017
Verlag
Springer Medizin
Erschienen in
Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 1/2017
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI
https://doi.org/10.1007/s00399-017-0486-2

Weitere Artikel der Ausgabe 1/2017

Herzschrittmachertherapie + Elektrophysiologie 1/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.